Purpose: The purpose of this meta-analysis was to evaluate patients' assessment of fentanyl iontophoretic transdermal system (ITS) and morphine intravenous patient-controlled analgesia (IV PCA) ease of care (EOC) using a validated patient EOC questionnaire. Fentanyl ITS is a preprogrammed, needle-free PCA system used for the management of acute pain in postoperative patients. Methods: This meta-analysis assessed the patient EOC of fentanyl ITS and morphine IV PCA using data from three randomized, active-comparator trials in adult postoperative patients with moderate-to-severe pain. All three studies utilized a validated patient EOC questionnaire which consists of 23 items grouped into seven subscales (confidence with device, comfort with device, movement, dosing confidence, pain control, knowledge/understanding, and satisfaction). Each item is scored on a six-point Likert scale. The weighted mean difference between treatments was calculated for the overall EOC and for each of the seven subscales. Results: The EOC analyses were based on responses to questionnaires from 1,943 patients treated with either fentanyl ITS (n 5 961) or morphine IV PCA (n 5 982). There was a statistically significant advantage in favor of fentanyl ITS over morphine IV PCA in terms of overall EOC (weighted mean difference 5 0.28; 95% confidence interval (0.22 to 0.34); P , 0.0001). Five of the seven subscales (confidence with device, comfort with device, movement, dosing confidence, and knowledge/understanding) on the patient EOC questionnaire showed a statistically significant advantage for fentanyl ITS versus morphine IV PCA. The two subscales that did not show any difference were pain control (P 5 0.7303) and satisfaction (0.0561). Conclusion: In this meta-analysis, fentanyl ITS is associated with some advantages in terms of an EOC profile from a patients' perspective when compared with morphine IV PCA.
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EFFECTIVE POSTOPERATIVE PAIN MANAGE-
MENT is critical to successful outcomes including early mobilization, increased patient satisfaction, and reduced hospital stay and costs. 1 Conversely, ineffective postoperative pain management can have some long-term consequences including the development of chronic pain. 2 Patientcontrolled analgesia (PCA) is commonly used to treat postoperative pain as part of a multimodal treatment regimen. 3, 4 However, with either intravenous (IV) or epidural PCA systems, there are potential pitfalls which include reduced mobilization as the patient is connected to the PCA pump and the potential for programming errors. [5] [6] [7] [8] [9] Fentanyl iontophoretic transdermal system (ITS) is a noninvasive PCA system that is utilized for the treatment of postoperative pain ( Figure 1 ). Fentanyl ITS is a preprogrammed, needle-free delivery system that utilizes iontophoresis whereby the drug is delivered through the skin via a nearly imperceptible electric current. 10 The health care provider assembles the system by snapping the controller (the top half of the device containing all electronics) and drug unit (the bottom half containing the 10.8 mg of fentanyl HCl) together immediately before application to the patient. The system is held on the skin with adhesive. Fentanyl ITS delivers a preprogrammed analgesic dose based on the patients control. The use of fentanyl ITS reduces the need for venous access for pain management, eliminates the potential for programming errors, and minimizes the potential for medication errors. 11 In addition, staff time spent on PCA administration may be reduced with the fentanyl ITS and therefore can be utilized for direct patient care. 12, 13 Postoperative patient mobility is essential to recovery and is important for preventing complications after major surgery.
14 Fentanyl ITS has the potential to increase patients' mobility since no IV or epidural lines or equipment such as pumps and poles are needed for analgesia.
The efficacy and safety of fentanyl ITS have been well studied. In four phase 3B randomized, active-comparator trials, fentanyl ITS demonstrated an equal efficacy and similar safety profile to morphine IV PCA. [15] [16] [17] [18] From a dosing perspective, in the phase 3B trials, a fentanyl ITS 40 mcg dose over 10 minutes for up to six doses/ hour was approximately equianalgesic with morphine IV PCA 1-mg morphine bolus doses for up to 10 doses/hour with a 5-or 6-minute lockout periods between doses.
A previous report on the patients' perspective of ease of care (EOC) has been reported using data from two of the phase 3B studies. 19 That analysis was performed using a simple pooled analysis technique (ie, the analysis was performed as if the data were derived from a single sample). In this current analysis, we are using data from three of the four phase 3B trials (the fourth study did not collect the patient EOC questionnaire), and we are utilizing a meta-analytic technique. Meta-analysis allows detection of treatment effects with greater power This report represents the first ever conducted meta-analysis comparing fentanyl ITS with morphine IV PCA EOC from a patients' perspective.
Methods
PubMed, Cochrane Library, and Google Scholar were searched combining the terms ''fentanyl'' ITS, iontophoretic transdermal system; IV PCA, intravenous patient-controlled analgesia; NA, not available; SD, standard deviation.
Treated population included any patients that received study treatment. and ''iontophoretic'' and ''ease of care'' for the period of 1980 to August 1, 2015. Studies were included if they studied fentanyl ITS and had used the validated patient EOC questionnaire. 21 The manufacturer also provided information regarding their phase 3B clinical studies. One pooled analysis that detailed the results of two studies was included from the literature, 19 and one study was included from the manufacturer. The manufacturer indicated that only three studies in the clinical development program had utilized the validated patient EOC questionnaire. All data relating to the patient EOC questionnaire were provided by the manufacturer relating to these three studies. At the time that the meta-analysis was conducted, fentanyl ITS was not commercially available, and therefore no additional studies could have been performed. Therefore, all studies that had been conducted with fentanyl ITS and utilized the validated patient EOC questionnaire were included.
A meta-analysis was conducted using data from all of the active-comparator phase 3B studies that compared fentanyl ITS with morphine IV PCA and utilized the validated patient EOC questionnaire. [15] [16] [17] Details of the studies are included in Table 1 . In these studies, patients were randomly assigned to receive either fentanyl ITS or morphine IV PCA. Patients in the fentanyl ITS group received a 40-mcg dose over 10 minutes for up to six doses/ hour for 24 hours or a maximum of 80 doses per system (whichever occurred first), after which a new system could be applied if needed. Patients treated with morphine IV PCA received 1-mg morphine bolus doses for up to 10 doses/hour with a 5-or 6-minute lockout periods between doses (depending upon site-specific polices) for 24 hours (up to a maximum of 240 doses).
The patient EOC questionnaire is a validated tool which consists of 23 items grouped into seven subscales (confidence with device, comfort with device, movement, dosing confidence, pain control, knowledge/understanding, and satisfaction; Figure 2 ). All items, with the exception of the satisfaction items, were scored on a six-point Likert scale (0 5 not at all; 1 5 a little bit; 2 5 somewhat; 3 5 quite a bit; 4 5 a great deal; and 5 5 a very great deal; Figure 2 ). The satisfaction items were scored on a six-point Likert scale (0 5 extremely dissatisfied; 1 5 very dissatisfied; 2 5 dissatisfied; 3 5 satisfied; 4 5 very satisfied; and 5 5 extremely satisfied; Figure 2 ). During the analysis, items 1 to 5, 10, and 13 to 21 were transformed so that higher scores indicated more favorable results on the questionnaire.
Statistical Analysis
The meta-analysis was conducted using random effects model which is a conservative statistical method. 22 Analyses using random effects models assume that the results are to be generalized to the entire patient population and have been previously Weighted mean scores were calculated for each individual item in the questionnaire and for the overall EOC as well as the subscales. During the analysis, we integrated patient EOC questionnaire data of 23 items from three active-controlled studies with items 1 to 5, 10, and 13 to 21 transformed so that higher scores indicated more favorable results on the questionnaire. In addition to evaluating mean scores, post hoc analyses were completed evaluating responders. A responder for each of the six subscales included in the overall EOC (satisfaction was not included) was defined as a patient who responded with one of the three most positive choices of the Likert scale on all items of a subscale. A responder for overall EOC was defined as a patient who responded with one of the three most positive choices for all 21 items in the six subscales included in the overall EOC calculations (ie, confidence with dosing, comfort with device, movement, dosing confidence, pain control, and knowledge/understanding subscales). A responder on the satisfaction subscale was defined as a patient who responded with one of the two most positive choices of the Likert scale on both items of the subscale.
For continuous variables, the weighted mean difference (WMD) between treatments was calculated. For dichotomous variables, odds ratios (ORs) indicating the probability of the outcome to occur for a patient receiving fentanyl ITS versus morphine IV PCA were calculated. Statistical tests were performed at the .05 significance level, with no multiplicity adjustments. Ninety-five percent confidence intervals (CIs) were provided for all parameters.
Results
Three phase 3B studies in the fentanyl ITS development program measured patient EOC via a validated questionnaire, and a total of 1,965 patients Figure 4 . Mean scores for patient EOC subscales. Weighted means difference and P value were based on random effect model for meta-analysis. Overall EOC score was calculated as mean of subscale scores. Each subscale score was average of nonmissing items comprising subscale. Higher difference means ''favors fentanyl ITS.'' EOC, ease of care; CI, confidence intervals; ITS, iontophoretic transdermal system; IV PCA, intravenous patient-controlled analgesia; WMD, weighted mean difference.
were included in this analysis. The mean age of patient ranged from 50.2 years to 62.9 years (Table 1 ). In the studies that measured body mass index, the mean was between 29.2 and 29.8 kg/ m 2 . The majority (86.5%) of patients completed the study (Table 1) .
Patient EOC

MEAN SCORE COMPARISONS.
There was a statistically significant benefit in favor of fentanyl ITS over morphine IV PCA in terms of the patients' overall EOC (WMD 5 0.28 [95% CI: 0.22 to 0.34], P , 0.0001; Figure 3 ). There was a statistically significant benefit in favor of fentanyl ITS over morphine IV PCA in terms of the five of the seven The WMD was also calculated for each item ( Figure 5 ). There was a statistically significant WMD in favor of fentanyl ITS for 14 of the 23 items. Figure 5 . Analysis of EOC from patients by item (mean score). Weighted means difference and P value were based on random effect model for meta-analysis. Higher difference means ''favors fentanyl ITS''. During the analysis, items 1-5, 10, and 13-21 were transformed, so that higher scores indicated more favorable results on the questionnaire. EOC, ease of care; CI, confidence intervals; ITS, iontophoretic transdermal system; IV PCA, intravenous patientcontrolled analgesia; WMD, weighted mean difference.
COMPARING FENTANYL ITS VS MORPHINE IV PCA
There were no items where morphine IV PCA was favored over fentanyl ITS.
RESPONDER DATA. Significantly greater percentages of patients were considered responders in the fentanyl ITS group (37.9%) compared to the morphine IV PCA group (26.4%) for the patient overall EOC (OR: 1.689 [1.293, 2.208], P 5 0.0001; Figure 6 ). There were also significantly greater percentages of patients who were considered responders in the fentanyl ITS group compared to the morphine IV PCA group in five of the seven subscales including confidence with device, mobility, dosing confidence, knowledge/ understanding, and satisfaction ( Figure 5 ). There was no difference in either the comfort with device or pain control subscales in terms of responders.
Discussion
In this meta-analysis, there was a statistically significant difference in favor of fentanyl ITS over morphine IV PCA in terms of overall EOC from the patients' perspective. For five of the seven subscales (confidence with device, comfort with the device, mobility, dosing confidence, and knowledge/understanding), fentanyl ITS was statistically significantly superior to morphine IV PCA; in the remaining two subscales (pain control and satisfaction), there was no difference between treatments. Similar results were obtained when a responder analysis was completed. The only difference between the WMD analysis and the responder analysis was that there was no difference in comfort with device in the responder analysis although there had been in the WMD analysis and satisfaction statistically significantly favored fentanyl ITS over morphine IV PCA in the responder analysis. In both analyses, pain control was equivalent between the two treatments.
Mobility is very important for patients especially in terms of ambulation. Each of the mobility subscale items and the mobility subscale showed a statistically significant difference in favor of fentanyl ITS Figure 6 . Patient responder for subscales. Odds ratio and P value were based on random effect model for metaanalysis. A responder for each of the six subscales included in the overall EOC (satisfaction was not included) was defined as a patient who responded with one of the three most positive choices of the Likert scale on all items of a subscale. A responder for overall EOC was defined as a patient who responded with one of the three most choices for all 21 items in the six subscales included in the overall EOC calculations (ie, confidence with dosing, comfort with device, movement, dosing confidence, pain control, and knowledge/understanding subscales). A responder on the satisfaction subscale was defined as a patient who responded with one of the two most positive choices of the Likert scale on both items of the subscale. CI, confidence interval; ITS, iontophoretic transdermal system; IV PCA, intravenous patient-controlled analgesia; OR, odds ratio. treatment versus morphine IV PCA treatment. The items include both mobility in the bed and ambulation out of the bed. Postoperative patient mobility is one of the most important factors for preventing complications after major surgery (including, but not limited to pneumonia, pulmonary embolus, deep vein thrombosis, urinary tract infection). [23] [24] [25] [26] Early mobilization is also important in improving the quality of care and reducing length of stay in the hospital. 24, 26, 27 In addition, early patient mobility/ambulation is one of the key principles of enhanced recovery after surgery protocols. 28, 29 While the satisfaction subscale analysis was not statistically significant (WMD 5 0.14 [95% CI: 0.00 to 0.28], P 5 0.0561), the number of patients who were responders on the satisfaction subscale did show a statistically significant difference in favor of fentanyl ITS (fentanyl ITS: 75.3% vs morphine IV PCA 69.0%; OR: 1.366 [95% CI: 1.15 to 1.675], P 5 0.0026).
Extensive patient testing determining ease of use has been completed with the fentanyl ITS system in the form of human factors studies. 30 The majority of patients in these studies found the system very easy to use with very little training. This finding is confirmed in this study as both subscales in the patient EOC that specifically deal with handling of the device (ie, confidence with device and dosing confidence) showed statistically significant differences in favor of fentanyl ITS over morphine IV PCA. Therefore, the results of the human factors study and this meta-analysis demonstrate that the fentanyl ITS system is easy to use from the patients' perspective.
Conclusion
These results show significant advantages for fentanyl ITS over morphine IV PCA in terms of patients' perspective of EOC. In this study, patients found fentanyl ITS very easy to use. There was a significant benefit seen in terms of mobility which included both movement in the hospital bed and ambulation in favor of fentanyl ITS over morphine IV PCA. Fentanyl ITS offers potential advantages from the patients' perspective over traditional IV PCA while still obtaining the same level of efficacy.
